EBS

Emergent BioSolutions Inc. $6.38 1M +42.1% 3M -23.3% YTD -49.0% as of 2026-09-14
+Watchlist

↑↓ next ticker · ⌘+↑↓ or scroll to zoom · ←→ pan · 0 reset

▲ buy   ▼ sell  ·  size ≈ trade size  · earnings ● beat ● miss  ·  ring ◯ before open ◯ after close  · ─ moving averages · click the buttons above to hide them

Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
-0.0%
Next 1 week
-1.2%
Next 1 month
-0.8%
Seasonality
Weak window historically
Next 30 days (to Oct 15): -3.1% median, 42% of the last 19 years finished up.
20-year seasonality chart →
Mean reversion
Overbought — RSI(2) at 87
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is -0.14%/day.
Mean-reversion stats →
1-month breakdown — Market · β 1.15 -0.5% · Seasonal tilt -0.3%
$7M/day volume 78% volatility -22% 1-year
52-week range · 21% of the way up · -55% from the high
$4.36$14.06

Congressional trades in EBS Full tracker →

3 members · 7 buys / 6 sells · $27K–$230K disclosed · latest filing Jan 10, 2025.

SELL SC Steve Cohen · traded Dec 11, 2024 $1K–$15K
SELL JG Josh Gottheimer · traded Nov 5, 2021 $1K–$15K
BUY JG Josh Gottheimer · traded Oct 18, 2021 $1K–$15K
SELL JG Josh Gottheimer · traded Sep 15, 2021 $1K–$15K
SELL JG Josh Gottheimer · traded Feb 23, 2021 $1K–$15K
BUY GC Gilbert Cisneros · traded Nov 24, 2020 $1K–$15K
BUY GC Gilbert Cisneros · traded Jul 30, 2020 $1K–$15K
BUY GC Gilbert Cisneros · traded Jun 19, 2020 $1K–$15K

Earnings Full history →

Next report 2026-10-28 (Wednesday, after close, in 43 days) · EPS est. -0.39.

1-day std dev
17.4%
Finished up
48%
Biggest pop
+71.0%
Biggest drop
-42.0%

Standard deviation of the close-to-close move over the last 60 reports. History, not a forecast.

Data from the U.S. House Clerk and FINRA, plus end-of-day prices. Not investment advice.